Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency recognized psilocybin as a breakthrough therapy for treatment-resistant depression. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 81

Law Research and Development Therapy DEA 81

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 88

Marijuana Therapy Data THC 88

WeedAdvisor

SEPTEMBER 16, 2019

A 2017 study examined 84 products from 31 different brands and found that 70% of these items were mislabeled. The DEA flat-out stated that they have bigger priorities, focusing instead on deadlier drugs like methamphetamine. WeedAdvisor’s Concern for Public Safety. . Large-Scale Mislabeling. . However, vapes are not included.

CBD 45

CBD Vaping DEA Oil 45

Cannabis Law Report

JUNE 15, 2021

Charges HHS with establishing a “Commission on Substance Use, Health and Safety,” to determine the benchmark amounts for drug possession and publish an online report on their findings within 180 days. Ensures individuals with drug convictions can gain access to drivers’ licenses. to Decriminalize Drug Use and Possession.

Decriminalization 60

Decriminalization Policy Research and Development Data 60

Cannabis Law Report

MAY 17, 2019

Seq (1970) and Drug Enforcement Administration’s (“DEA”) clutches, 2019 hemp production and sales exploded. up 116% over Q3 2017); and $13.6 A wildly popular nutritional supplement and food additive, oil based hemp derived products like CBD racked up $1.1 stores and up 57% from prior year); $16.8 Budgeted at $6.1

Food 10

Food DEA Hemp CBD 10

Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

MAY 1, 2019

For a business which has decided to publish ads for cannabis businesses, there are a number of steps that would minimize the risk of receiving a call from a federal prosecutor or a visit from your local DEA agent. See Medicinal and Adult-Use Cannabis Regulation and Safety Act, Cal. FOOTNOTES. & Prof. Code § 26032. 2 Ajax Letter.

Legalization 45

Legalization Business Law Cannabis 45

Canna Law Blog

AUGUST 25, 2020

The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!

DEA 98

DEA Therapy Decriminalization Pharmaceutical 98

Canna Law Blog

AUGUST 25, 2020

The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!

DEA 98

DEA Therapy Decriminalization Pharmaceutical 98

Meadow

JULY 13, 2018

If you heard a couple weeks ago, maybe a month ago, DEA, FBI, IRS all came in Sacramento and they busted a whole bunch of homes. What I do on a regular basis is very much similar to what my colleagues and peers do here. It’s every square inch of it. Blowing up transformers in the backyards, they’re pulling so much power and it’s organized.

Wellness and Beauty 40

Wellness and Beauty Policy Consumption Cannabis 40

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Canna Law Blog

MARCH 4, 2020

And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly. The FDA doesn’t have any regulations on point for the control and oversight of ketamine clinics when it comes to infusion therapy and the states don’t really either.

Legalization 55

Legalization Therapy Chronic Pain DEA 55

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” In 2017, the FDA designated MDMA a breakthrough therapy for PTSD. Johnson & Roland R.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

DECEMBER 1, 2019

1595 [the Secure And Fair Enforcement (SAFE) Banking Act of 2019] was introduced to increase public safety by expanding financial services to marijuana-related legitimate businesses and service providers and reducing the amount of cash at such businesses. None of these bills has been passed by Congress so far. Comm’r , T.C. In Beck v.

Marijuana 59

Marijuana Business State Laws DEA 59

CannaMD

SEPTEMBER 15, 2020

A special legislative session in June 2017 passed Senate Bill 8A , the Medical Use of Marijuana Act , to implement rules for making medical marijuana available to Floridians. To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. In practice, however, it’s very ambiguous.

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

SEPTEMBER 19, 2019

Here are three of the most pressing matters that might give Congress absolutely no choice but to surrender to marijuana legalization in the interest of public health and safety. . A 2017 study published in ACS Omega by Jiries Meehan-Atrash, Wentai Luo and Robert M. hemp and marijuana.

Vaping 55

Vaping Hemp Education Patients 55

The Joint Blog

JUNE 2, 2020

Remember that he made a similar comment in May 2017 when signing that fiscal year’s appropriations bill into law, and yet no raids against state-legal medical marijuana patients or providers followed. The issue of legalization is left to the state, taking the health and safety of the public into account. During her speech on Feb.

Decriminalization 29

Decriminalization Recreational Advocacy Policy 29